Table 2.
Campaign Area | Average Annual Cases of NT, No. |
TT2 Coverage, % |
||||
---|---|---|---|---|---|---|
2009–2011 | 2012–2013 | % Change | 2009–2011 | 2012–2013 | % Change | |
No PsA-TT campaignsa | 121.9 | 139.5 | +14.4% | 85.6 | 79.2 | −7.4% |
Before campaign | After campaign | % change | Before campaign | After campaign | % change | |
Campaigns in part of countryb | 64 | 68 | +6.5% | 86.6 | 85.8 | −0.9% |
Campaigns covering all countryc | 260.2 | 194.5 | −25.4% | 82.2 | 81.0 | −2.5% |
Abbreviations: NT, neonatal tetanus; PsA-TT, group A meningococcal conjugate vaccine; TT2, second dose of tetanus toxoid.
a Côte d'Ivoire, Ethiopia, Mauritania, Democratic Republic of Congo, Guinea, Central African Republic.
b Cameroon, Togo, Benin, Ghana.
c Burkina Faso, Mali, Niger, Gambia, Chad, Senegal.